Neuropsychiatric disorders related to interferon and interleukins treatment.
about
Targeting the indoleamine 2,3-dioxygenase pathway in cancerQuinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory HypothesisAlterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.Brain interleukin-15 in neuroinflammation and behavior.The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.The association of infectious agents and schizophrenia.History and current state of immunotherapy in glioma and brain metastasis.Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attentionIdentification of a variable number of tandem repeats polymorphism and characterization of LEF-1 response elements in the promoter of the IDO1 geneReovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice culturesHypothalamic mechanisms in cachexia.EPR and Mössbauer spectroscopy show inequivalent hemes in tryptophan dioxygenase.Infectious Agents are Associated with Psychiatric Diseases.Cognitive assessment of patients with minimal hepatic encephalopathy in BrazilReliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment.Structural variants of IFNα preferentially promote antiviral functions.Psychiatric Adverse Effects Of Interferon Therapy.Association between Intracellular Infectious Agents and Schizophrenia.Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cellsTLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation.Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia.Beta-trace Protein as a new non-invasive immunological Marker for Quinolinic Acid-induced impaired Blood-Brain Barrier Integrity.Psychotic features associated with multiple sclerosis.Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies.The role of inflammatory cytokines on the aetiopathogenesis of depression.Cognitive consequences of a sustained monocyte type 1 IFN response in HIV-1 infectionInflammatory mediators of cognitive impairment in bipolar disorder.Cognitive and Affective Symptoms Experienced by Cancer Patients Receiving High-Dose Intravenous Interleukin 2 Therapy: An Integrative Literature Review.Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease.The Relationship between Tourette's Syndrome and Infections.Baseline Comorbidities Enhance the Risk of Treatment-Induced Depression in HCV-Infected Men: A Pilot Study.Birth cohort testing for hepatitis C virus: implications for clinical social workers in health care settings.Anorexia-cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma.Benznidazole treatment reduces the induction of indoleamine 2,3-dioxygenase (IDO) enzymatic activity in Chagas disease symptomatic patients.Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.Letter to the editor: does ketamine exert a fast-acting antidepressant effect via inhibition of pro-inflammatory cytokines?Persistent pro-inflammatory cytokines following the initiation of pegylated IFN therapy in hepatitis C infection is associated with treatment-induced depression.
P2860
Q26775471-70D7A262-7777-4C36-98B8-AC41A6618577Q28607691-A14DD204-FE8A-4165-8BCD-795E4AFFA6E8Q30372214-47AAC304-7A83-4EA1-8ACB-2EFB9E4DAFA0Q30443708-A7B55334-40BD-4ED0-865C-D0C0A0EC0F7CQ30476952-C47282C4-127F-4C2B-96E1-9A0FCD01E557Q33625298-8001ECD4-D31B-468F-B2B4-DF224630E042Q33656811-3881D6AE-9B71-4FD1-BC9E-91A9BEA7392DQ33975559-771F88C9-BDC2-44D6-A041-05D75B89B11AQ34043256-1640E559-66A0-40F1-8B20-F5C2DFBA7D60Q34053640-FA982EB2-BF73-408C-AB2D-BD8567D3FDA9Q34064890-D03CB8BC-46EB-467A-AF47-0DAD9CBF2ED3Q34081332-C58991C1-21C2-4F79-8B01-6375C5AA4D55Q34090851-687681F0-F77D-4AA3-87FB-AF09CCC2A142Q34618873-BF03EDF5-D593-4472-92BA-FF78C7C31224Q34691867-B341CE76-BA3C-455F-8C44-D40FDF88077CQ35184927-53248126-7E0A-477F-B368-65A913223342Q35197399-2F0284F2-2C02-4C5A-B136-646ECC231EC5Q35713956-6752ACB6-D09C-4C83-9043-62DACFB4AE8EQ36600796-37BC0BD9-2AA6-41F0-B719-4C2F3F1B8081Q36610873-25ECCFA2-AE64-4942-A1A3-BD6C47ADC51CQ37349893-0C29C910-65CE-4999-8ABB-C41CB72584A0Q37479996-73512F4C-5090-4B01-BCF7-AD4C040747C9Q37690195-516A30D6-D790-4CDC-8F84-D19330DC2F70Q37710120-3AA816CA-E8D1-4439-B421-DBD559116CBAQ37820728-7CD449B0-214B-47E5-A1E4-7D66A266E346Q38103493-8BBAC6DB-4966-4FD1-B343-CCD6A4A2F319Q38214994-DA8BAD5F-B5DF-42D4-9B1B-09F39997B83CQ38215023-EFCEA61C-8A32-4F34-B8B6-CDF7AF9F96CEQ38657831-62C146AB-E40D-4C8D-BA4A-8BA878557A19Q39004668-F427A75C-DC27-441D-A4C8-CBFCD34CEEECQ39282122-34B8D328-1224-4396-97C4-4C0CA96050E0Q41916984-C85ADD62-2170-4325-8445-1F8F421D5445Q42239297-333BB0DD-FFD4-4A7D-8EA2-CEC16B535565Q42270225-CD302A9D-8C57-4B36-B63B-815B095E4AFEQ42290147-1B56FCEE-9261-4C4B-8AC0-418B0F74DF7CQ45813783-22895776-089F-4B00-ACCC-2EEE5D08801DQ47964432-7C7F0B10-FECE-40E9-BEDE-023A1B10A7F4Q48250701-AA2FFECA-FC16-44C5-9DBB-B1AAD68D1F2FQ48949896-33145E43-0D3C-4336-8646-D7C52DE68DBF
P2860
Neuropsychiatric disorders related to interferon and interleukins treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuropsychiatric disorders related to interferon and interleukins treatment.
@en
Neuropsychiatric disorders related to interferon and interleukins treatment.
@nl
type
label
Neuropsychiatric disorders related to interferon and interleukins treatment.
@en
Neuropsychiatric disorders related to interferon and interleukins treatment.
@nl
prefLabel
Neuropsychiatric disorders related to interferon and interleukins treatment.
@en
Neuropsychiatric disorders related to interferon and interleukins treatment.
@nl
P2093
P2860
P1476
Neuropsychiatric disorders related to interferon and interleukins treatment.
@en
P2093
Aye Mu Myint
Brian E Leonard
Markus J Schwarz
P2860
P2888
P356
10.1007/S11011-008-9114-5
P577
2008-12-10T00:00:00Z